Ozelo MC, Luciani M, Glosli H, Kavakli K, Samji N, Makris GC, Tueckmantel C, Maas Enriquez M, Oliveira LC, Gupta S, Arbesú MG, Davoli M, Chan AKC, Mancuso ME(2026) Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study Eur J Haematol(in press) DOI 10.1111/ejh.70059, PubMed 41486550
Weedon-Fekjær MS, Pihlstrøm HK, Weedon-Fekjær H, Berentsen B, Hatlebakk JG, Bjerkely B, Solberg OK, Heimdal KR, Ørstavik K, Jenssen TG, Sigurdardottir S(2025) Gastrointestinal symptoms in adults with Fabry disease and their associations with physical and mental health BMC Gastroenterol, 25(1), 819 DOI 10.1186/s12876-025-04439-0, PubMed 41257599
Daae E, Feragen KB, Nærland T, von der Lippe C(2025) Health care professionals' experiences of caring for children with severe epidermolysis bullosa Health Psychol Open, 12, 20551029251391232 DOI 10.1177/20551029251391232, PubMed 41209394